The most common glucuronidation sites are nucleophilic O or N atoms of the sugar acceptor substrate. Glucuronidation occurs as an S N 2 substitution by the attack of a nucleophilic heteroatom of the aglycone on the C 1 atom of glucuronic acid, while both UDPGA and the aglycone substrate are bound on the active site of the enzyme. The S N 2 mechanism is supported by inversion of the α-configuration of the C 1 atom to β-configuration in the glucuronide (Johnson and Fenselau, 1978) , and by the substituent effects on the glucuronidation rate (Yin et al., 1994) . The 3D structure of the active site is unknown. A unanimous conclusion of all previous mechanistic studies is that the reaction involves the formation of a ternary complex (Potrepka and Spratt, 1972; Vessey and Zakim, 1972; Sanchez and Tephly, 1975; Rao et al., 1976; Koster and Noordhoek, 1983; Falany et al., 1987; Matern et al., 1991; Yin et al., 1994) . Product and dead-end inhibition studies conducted to determine the order of substrate binding have given ambiguous results, however. Two reports based on partially purified rat UGTs (Falany et al., 1987; Yin et al., 1994) , and one report based on beef liver microsomes (Vessey and Zakim, 1972) have proposed a random ordered bi bi mechanism, while other studies with animal tissue fractions have proposed a compulsory ordered bi bi (Potrepka and Spratt, 1972; Sanchez and Tephly, 1975; Koster and Noordhoek, 1983) or a Theorell-Chance mechanism (Rao et al., 1976; Koster and Noordhoek, 1983) .
The availability of recombinant UGTs has aided in understanding the contribution of glucuronidation to xenobiotic metabolism. Substrate specificities of human UGTs have been characterized by determining specific activities and kinetic parameters for a large number of substrates. Nevertheless, the role and significance of individual UGT isoforms are still poorly understood, and the bisubstrate kinetics of UGTs has not previously been studied with individual isoenzymes. Meaningful substrate specificity assessment can only be made after the catalytic constants (k cat ), and especially the specificity constants (k cat /K m ), have been determined, or at least bisubstrate kinetics should also be determined. Detailed study of the kinetic mechanism of UGTs could also assist the design of potent and specific inhibitors.
To better understand the kinetics of glucuronidation, we studied the bisubstrate kinetics of eight human recombinant UGTs of the 1A subfamily. The kinetic mechanism and substrate inhibition were characterized and the substrate specificities were evaluated on the basis of relative specificity constants.
Materials and methods

Materials.Insect cell membranes containing one of the following human UGTs-1A1, 1A3, 1A4
and 1A6-1A10-together with purified UG1A9, were prepared in our laboratory as previously described Kuuranne et al., 2003) . Phosphatidylcholine X-E from dried egg yolk, ethinylestradiol, scopoletin, 4-aminobiphenyl, 1-naphthol, 4-hydroxyestrone, 4-nitrophenol, umbelliferone, uridine 5´-diphosphate sodium salt (UDP), D-saccharic acid 1,4-lactone (saccharolactone), and uridine 5´-diphosphoglucuronic acid trisodium salt (UDPGA) were purchased from Sigma-Aldrich (St Louis, MO), and 1-hydroxypyrene was from Acros Organics (New Jersey, USA). Entacapone was kindly provided by Orion Pharma (Espoo, Finland), and entacapone glucuronide (Luukkanen et al., 1999) , 1-hydroxypyrene glucuronide (Luukkanen et al., 2001) , and scopoletin glucuronide were synthesized in our laboratory. α-Naphthyl-β-Dglucuronide, 4-nitrophenyl-β-D-glucuronide, and umbelliferyl-β-D-glucuronide were purchased from Sigma-Aldrich (St Louis, MO of the appropriate recombinant UGT or 50 ng of purified UGT1A9. Phosphatidylcholine type X-E
(1 mg/ml) was added to the assay mixtures containing the purified UGT1A9. The aglycone substrate concentrations ranged from ca. 0.2 to 10 times the respective K m values (determined in preliminary assays) unless method sensitivity or substrate solubility demanded otherwise. The aglycone substrates were added as DMSO solutions to a final DMSO concentration of 2% in all the enzyme assays. All samples were prepared in duplicate.
The reactions were performed at 37°C and the reaction time varied, within the linear range, from 10 to 60 min. The reactions were terminated by the addition of 25 µl of 4 M ice-cold perchloric acid or 250 µl of ice-cold methanol (4-aminobiphenyl). The precipitated proteins were removed by centrifugation (5 min at 14 000 rpm). Blank incubations were prepared in a similar way at the highest aglycone substrate concentrations without UDPGA.
Aliquots of the supernatants were analyzed using an Agilent model 1100 or a Hewlett Packard model 1090 HPLC with UV or fluorescence detection. Details of the analytical conditions are given in Table 1 . The quantitation of entacapone glucuronide, 1-naphthylglucuronide, 1-hydroxypyrene glucuronide, scopoletin glucuronide, and 4-nitrophenylglucuronide was based on authentic reference standards. When pure glucuronide was not available the quantitation of the glucuronidated products was achieved with the HPLC connected to a flow scintillation analyzer (150TR, Packard, Meriden, CT) that was fitted with a 500-µl flow cell into which 3 ml/min of scintillation liquid (Monoflow 3, National Diagnostics, Atlanta, GA) was pumped. The radiochemical detection was coupled to UV or fluorescence detection as described previously (Kaivosaari et al., 2001) .
Product inhibition studies with UDP (UGT1A9) were conducted at sub-saturating (100 µM)
concentrations of the fixed substrate. Inhibition studies with a competing substrate, 1-naphthol, were conducted at 100 µM entacapone when UDPGA was the varied substrate, and at 1000 µM UDPGA when entacapone was the varied substrate. UDP was added to the reaction mixture as an aqueous solution to a final concentration of 0, 25, 50, 100, 250, or 500 µM, and 1-naphthol in DMSO was added to a final concentration of 0, 0.5, 2.5, or 10 µM.
Protein concentrations were measured using the bicinchoninic acid (BCA) protein assay kit (Pierce, Rockford, IL) with bovine serum albumin as standard, and the relative enzyme concentrations in the membranes were estimated by dot-blot analyses as described recently (Kurkela et al., 2004) .
Kinetic analysis.Kinetic parameters were estimated by fitting the initial rate data to appropriate bisubstrate and inhibition rate equations (Cornish-Bowden, 1995; Copeland, 2000) by nonlinear least-squares regression using a weighting factor 1/y. Data analysis was performed by SigmaPlot
Enzyme kinetics module 1.1S and the goodness of fit was evaluated on the basis of standard deviations of the parameter estimates, R 2 values, and residual plots. The individual rate constants for the glucuronidation of scopoletin by purified UGT1A9 were calculated according to CornishBowden (Cornish-Bowden, 1995) .
Results
Kinetic mechanism. The initial rates for the reactions catalyzed by the recombinant human UGTs 1A1, 1A3, 1A4, 1A6, 1A7, 1A8, 1A9, and 1A10 were determined by varying the concentrations of both substrates: the sugar donor UDP-glucuronic acid (AX) and the sugar acceptor (B). The measured initial rates were in good agreement with a ternary complex mechanism, for which the reaction velocity can be given by equation 1 or equation 2 (Copeland, 2000) , where K AX is the dissociation constant for the enzyme-AX complex, K B is the dissociation constant for the enzyme- Fig. 2A) assuming rapid equilibrium and equation 2 is derived for compulsory ordered bi bi mechanism (Fig. 2B ) using steady state assumptions.
The bisubstrate initial rate data for all UGT1A enzymes gave a good statistical fit to both equations 1 and 2 up to aglycone substrate concentrations at least 4-5 times the respective K m values (Table 2) and up to UDPGA concentrations of 1-5 mM. Fit of the kinetic data to equation 2 is shown in Fig.   1 . At higher aglycone concentrations, substrate inhibition was observed for all UGT1A isoforms except UGT1A4. At very high concentrations of both substrates (above 2 mM), the measured velocity data showed irregular behavior and poor reproducibility. In the case of UGT1A3, the high K m for scopoletin limited the rate determination to a concentration of aglycone of only twice the
Substrate inhibition is expected for a ternary complex mechanism following compulsory ordered kinetics. As depicted in Fig. 2B , binding of the aglycone substrate to the enzyme-UDP complex leads to a non productive dead-end complex that slows the completion of the catalytic cycle. In such a case the reaction velocity is given by equation 3:
where K siB is a constant that describes the strength of substrate inhibition. This article has not been copyedited and formatted. The final version may differ from this version. The bisubstrate kinetic data for 1A1, 1A8, 1A9 and 1A10, including conditions of high aglycone substrate concentration, fitted well to equation 3 (Fig. 3) . In the case of UGTs 1A3, 1A6, and 1A7, the substrate inhibition data was measured only at one UDPGA concentration and the data fitted well to the corresponding reduced equation (Eq. 4).
Although formation of the same non-productive complex is also possible in a mechanism that follows random ordered ternary complex kinetics ( Fig. 2A) , the formation should not occur, and substrate inhibition should not be seen if the mechanism involves rapid equilibrium, because then the concentration of the enzyme-UDP or enzyme-glucuronide complex is zero in the absence of added products. Observation of substrate inhibition may thus be used to exclude rapid equilibrium random ordered bi bi mechanism.
The results of the bisubstrate kinetic experiments suggest that glucuronidation catalyzed by UGTs 1A1, 1A3, and 1A6-1A10 does not involve rapid equilibrium, and the reaction most probably follows the scheme presented in Fig. 2B . Nevertheless, a non-rapid-equilibrium random ordered reaction according to Fig. 2A cannot be excluded on the basis of the bisubstrate kinetic data alone.
Two other possible mechanisms, rapid equilibrium compulsory ordered mechanism (TheorellChance) and the double displacement mechanism (Ping-Pong) (Copeland, 2000) can be excluded on the basis of the poor fit of the velocity data to the corresponding equations.
An inhibitor that binds to the same site as one of the substrates would kinetically distinguish between the two ternary complex mechanisms. In the case of compulsory ordered mechanism an inhibitor that resembles the second-binding substrate would be expected to bind to the enzymefirst-binding-substrate complex rather than to the free enzyme. Hence, a competitive inhibitor with This article has not been copyedited and formatted. The final version may differ from this version. respect to the second-binding substrate would behave as an uncompetitive inhibitor with respect to the first-binding substrate. In the case of a random ordered mechanism, on the other hand, no uncompetitive inhibition pattern should be observed. Carrying out of such an inhibition experiment has been hampered by the lack of effective UGT inhibitors that bind to the aglycone-binding site.
However, we found that 1-naphthol, although it is a substrate for UGT1A9, shows significantly higher affinity and lower reactivity (K m = 0.09 µM, V max = 27.8 pmol/ml/min) than entacapone (Table 2 ) and, hence, could be used as a competitive inhibitor with respect to entacapone in experiments with UGT1A9.
The effects of 1-naphthol on the kinetics of entacapone glucuronidation by UGT1A9 are shown in Fig. 4 . As can be seen, 1-naphthol acts as an uncompetitive inhibitor when UDPGA is the varied substrate ( Fig 4A) , and as a competitive inhibitor when entacapone is the varied substrate (Fig. 4B ).
Fitting the data to the general equation of reversible inhibition yielded dissociation constants of 0.191 µM and 1.46 µM for the binding of 1-naphthol to the enzyme-UDPGA complex and to the free enzyme, respectively. These results indicate that 1-naphthol also binds to the free enzyme, but with significantly lower affinity than to the enzyme-UDPGA complex. It is not unexpected to see some inhibitory binding of a hydrophobic substrate to the free enzyme, even though the catalytic binding would require compulsory order.
We also studied UDP inhibition of the entacapone glucuronidation reaction by UGT1A9. The results are presented in Fig. 5 . The inhibition by UDP displayed noncompetitive and competitive patterns with respect to entacapone ( Fig. 5A ) and UDPGA ( Fig. 5B ), respectively. Such inhibition patterns are possible in both random and compulsory ordered mechanisms. In the case of compulsory ordered reaction, the inhibitory behavior of UDP suggests that UDPGA is the firstbinding substrate. The dissociation constant K i for enzyme-UDP complex was found to be less than one-tenth the K i value for the enzyme-UDPGA complex (Fig. 5 ).
This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 6) . A consistent means of determining k cat requires knowledge of the absolute enzyme concentration and, hence, the total UGT1A9 concentration was calculated by means of the the total amount of protein in the purified enzyme. The apparent homogeneity of the purified UGT1A9 was demonstrated by SDS-Page and Western blotting .
In the case of a compulsory ordered bi bi mechanism, a unique relationship exists between the kinetic parameters and the rate constants (Fig. 7) . Hence, the individual rate constants k 1 and k -1 could be calculated from the initial rate measurements (Cornish-Bowden, 1995) .
The rate constants for the glucuronidation of scopoletin by purified UGT1A9 are presented in Fig.   6 . The first-order rate constant for the dissociation of the enzyme-UDPGA complex, k -1 =2. 
Discussion
The bisubstrate kinetics of eight recombinant human UGTs was analyzed. The glucuronidation reaction was well described by the rate equations derived for mechanisms involving the formation of a ternary complex. Nevertheless, the bisubstrate kinetics alone did not allow us to determine whether there was a compulsory order of binding of substrates. An unambiguous differentiation of the random and compulsory ordered mechanisms was established by the observed essentially uncompetitive inhibition by 1-naphthol with respect to UDPGA (Fig. 4A ). This result indicates that 1-naphthol preferably binds to the enzyme-UDPGA complex, that is, the reaction follows a compulsory ordered kinetic mechanism in which UDPGA is the first-binding substrate. The observed competitive inhibition by UDP with respect to UDPGA (Fig. 5B ) and noncompetitive inhibition with respect to entacapone (Fig. 5A ) provided further evidence for the compulsory ordered mechanism with UDPGA as the first-binding substrate.
Previous studies on the enzyme kinetic mechanism have provided different and sometimes conflicting results (Potrepka and Spratt, 1972; Vessey and Zakim, 1972; Sanchez and Tephly, 1975; Rao et al., 1976; Koster and Noordhoek, 1983; Falany et al., 1987; Yin et al., 1994) . The ambiguity of the results from product and dead-end inhibition experiments in earlier work may well be explained by the presence of several different UGT isoforms in the tissue samples, a fact that was not fully appreciated in the past. The presence of several isoforms would severely complicate the interpretation of inhibition kinetic data, especially when analyzed by means of linearized plots. In addition, those studies that relied on partially purified rat enzymes probably suffered from the presence of UGTs that were partially detergent-inactivated during the membrane solubilization and the purification process .
At high concentrations of both substrates, substrate inhibition was frequently observed with all UGT1A isoforms except 1A4. The only human UGT of the 1A subfamily for which we have not efficiently. An attempt was made to determine the enzyme kinetic parameters for the glucuronidation of 4-aminobiphenyl, which is a widely accepted model substrate for UGT1A4.
Although it was a good substrate for UGT1A4 when considering V max , the bisubstrate kinetics for 4-aminobiphenyl could not be determined reliably due to the combination of low solubility and poor method sensitivity. A hydroxylated PAH compound, 1-hydroxypyrene, exhibited a considerably lower K m but showed no substrate inhibition in the concentration range that was studied. The apparent substrate inhibition was used to exclude the rapid equilibrium random ordered bi bi mechanism. In the case of a compulsory ordered bi bi mechanism, substrate inhibition allows the identification of the second-binding substrate. The occurrence of substrate inhibition for UGTs 1A1, 1A3, and 1A6-1A10 suggests, therefore, that glucuronidation catalyzed by these isoforms does not involve rapid equilibrium, and that the reaction probably follows the scheme presented in Fig. 2B .
The K siB values (Table 3 .) were significantly higher than the corresponding K m values for all UGT1A isoforms, however, which means that of substrate inhibition is probably of negligible significance in physiological environment. As reported previously (Houston and Kenworthy, 2000; Uchaipichat et al., 2004) , substrate inhibition may also arise from the binding of a second substrate molecule to the enzyme-substrate complex. Nevertheless, the kinetic data fitted well to equations 3 and 4, and incorporation in the kinetic equation of a parameter describing the binding of a second substrate molecule resulted in poorer statistics of the fits.
Kinetic constants derived from bisubstrate reactions have not been reported previously for individually expressed UGT isoforms. The K m values for UDPGA have been determined at saturating aglycone substrate concentrations with recombinant human UGTs 1A1 (400-1810 µM) (Senafi et al., 1994; Court et al., 2001 ), 1A3 (250 µM), 1A4 (300 µM) (Green et al., 1995) , 1A6
(110-200 µM) (Battaglia et al., 1998; Ouzzine et al., 2000; Court et al., 2001), and 1A9 (190-500 This article has not been copyedited and formatted. The final version may differ from this version. (Cappiello et al., 2000) . The physiological concentrations of UDPGA only rarely exceed the K m values obtained in this study and speculations that a decrease in the availability of UDPGA would impair the capacity for hepatic glucuronide conjugation (Howell et al., 1986; Evdokimova et al., 2001 ) may be justified. A comparison of the aglycone K m values in Table 2 with the few published results for the same combinations of UGT isoform and substrate shows our values to be mostly within the same order of magnitude as the earlier ones, for example, those reported for UGT1A1 with ethinylestradiol (Williams et al., 2002; Soars et al., 2003) , UGT1A3
with scopoletin (Green et al., 1998) , and UGT1A6 with 1-naphthol (Uchaipichat et al., 2004) , as well as those reported for eight UGT1A isoforms with 4-methylumbelliferone (Uchaipichat et al., 2004 ).
The current study also has implications for the structure-function relationships of the UGTs. A close inspection of the K AX values in Table 2 The individual rate constants for the binding of UDPGA to the enzyme, the dissociation of the enzyme-UDPGA complex, and the product formation for the glucuronidation of scopoletin by purified UGT1A9 were calculated from the enzyme kinetic parameters (Fig. 6A ) assuming the enzyme follows compulsory ordered mechanism. The purified UGT1A9 presented a lower affinity for scopoletin and UDPGA than the native protein, as evidenced by significant increases in the K m and K AX values. Nevertheless, the specific activity of the purified enzyme was ca. 1000-fold higher than the value of the membrane-bound UGT1A9.
When [S]<<K m , the upper limit for the reaction rate is defined by the diffusional rate of encounter of the free enzyme with substrate, which is characterized by k 1 (typically 10 ) (Fig. 6) . The k cat value (1.9 s -1 ) for the formation of scopoletin glucuronide was 1-2 orders of magnitude higher than previously reported for the N-glucuronidation of N-hydroxy-PhIP by UGT1A9 (Malfatti and Felton, 2004) . However, UGT1A1 catalyzed the glucuronidation of N-hydroxy-PhIP at the highest rate, k cat =1.9 s -1 , which is in line with with our This article has not been copyedited and formatted. The final version may differ from this version. Table 2 . Fig. 2 . Scheme A presents a random ordered bi bi mechanism and scheme B a compulsory ordered bi bi mechanism. E=UGT, AX=UDP-glucuronic acid, B=aglycone substrate. Fig. 3 . The substrate inhibition kinetics for seven human recombinant UGTs. The initial rate data was fitted to the rate equation for ternary complex mechanism taking into account substrate inhibition (Eq. 3 and 4). Initial rate data was either from the bisubstrate kinetic analysis (25, 50, 100, 250, 500, 1000, 2500, and 5000 µM UDPGA), or determined at 1 mM UDPGA. The R 2 values varied from 0.864 to 0.994. A UGT1A1 (ethinylestradiol), B UGT1A3 (entacapone), C UGT1A6 (4-nitrophenol), D UGT1A7 (4-hydroxyestrone), E UGT1A8 (entacapone), F UGT1A9 (entacapone), G UGT1A10 (entacapone). Each data point represents the average of at least two replicates. Experimental details are presented in Materials and methods. For kinetic parameters see Table 3 .
This article has not been copyedited and formatted. The final version may differ from this version. Table 2 . for kinetic parameters. All data points are the average of two replicates. 
